Analyze Diet

Effect of intramuscularly administered polysulfated glycosaminoglycan on articular cartilage from equine joints injected with methylprednisolone acetate.

Abstract: Intra-articularly administered, long-acting corticosteroids are a beneficial treatment for many equine joint disorders because they alleviate inflammation and signs of pain, but they also exert detrimental effects on the biochemical composition and morphologic features of articular cartilage. Chondroprotective drugs have been shown to mitigate some of the deleterious effects of intra-articularly administered corticosteroids on articular cartilage of laboratory animals. Twenty-one ponies were assigned at random to receive 1 of 3 treatments in the right middle carpal joint. Group-1 ponies (n = 8) had methylprednisolone acetate (MPA; 0.2 mg/kg of body weight) and saline solution administered intra-articularly and IM, respectively. Group-2 ponies (n = 9) received MPA (0.2 mg/kg) and polysulfated glycosaminoglycan (GAG; 2 mg/kg). Group-3 ponies (control; n = 4) had saline solution administered intra-articularly and IM. The corticosteroid or saline solution was injected into the right middle carpal joint on day 1. The IM administered polysulfated GAG or saline solution was administered at the same time, then was repeated every 3 days for 20 days. Ponies were euthanatized 21 days after initial injection by overdose of pentobarbital sodium. The cartilage of younger ponies was significantly (P < 0.05) more responsive to the proteoglycan-depleting effects of MPA. Ponies < 10 years old of groups 1 and 2 had significantly (P < 0.05) lower GAG content in the articular cartilage than did control ponies. Systemic treatment with polysulfated GAG did not result in a protective effect against proteoglycan loss from the articular cartilage.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1993-08-01 PubMed ID: 8214910
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the impact of polysulfated glycosaminoglycan, when administered intramuscularly, on the articular cartilage of horses treated with a corticosteroid, methylprednisolone acetate. The paper suggests that despite corticosteroids being helpful in treating equine joint disorders, they can alter the biochemical and morphological properties of articular cartilage, to which the chondroprotective drugs might counteract.

Methodology

  • The study involved twenty-one ponies which were randomly assigned to one of three groups.
  • Group 1 (8 ponies) were treated with methylprednisolone acetate (MPA; 0.2 mg/kg of body weight) and a saline solution, both given intra-articularly, and the saline solution also given intramuscularly (IM).
  • Group 2 (9 ponies) received both MPA (same dosage as group 1) and polysulfated glycosaminoglycan (GAG; 2 mg/kg).
  • The control group (Group 3, 4 ponies) was given a saline solution both intra-articularly and IM.
  • The corticosteroid or saline solution was injected into the middle carpal joint on the first day. The polysulfated GAG or saline solution was then administered IM at the same time, and the dosage was repeated every three days for 20 days.

Results

  • Three weeks after the initial injection, the ponies were euthanatized and their cartilage was examined.
  • The researchers found that the articular cartilage in younger ponies was significantly more susceptible to the proteoglycan-depleting effects of MPA.
  • The study showed that the ponies below 10 years old in groups 1 and 2 had significantly lower GAG content in their articular cartilage than those in the control group.

Observations

  • The research indicates that the systemic treatment with polysulfated GAG did not protect against proteoglycan loss in the articular cartilage, contrary to the expectation that the drug would mitigate some of the damaging effects of corticosteroids on the cartilage.

Cite This Article

APA
Fubini SL, Boatwright CE, Todhunter RJ, Lust G. (1993). Effect of intramuscularly administered polysulfated glycosaminoglycan on articular cartilage from equine joints injected with methylprednisolone acetate. Am J Vet Res, 54(8), 1359-1365.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 54
Issue: 8
Pages: 1359-1365

Researcher Affiliations

Fubini, S L
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
Boatwright, C E
    Todhunter, R J
      Lust, G

        MeSH Terms

        • Animals
        • Anti-Inflammatory Agents / antagonists & inhibitors
        • Anti-Inflammatory Agents / metabolism
        • Cartilage, Articular / drug effects
        • Cartilage, Articular / metabolism
        • Fibronectins / metabolism
        • Glycosaminoglycans / metabolism
        • Glycosaminoglycans / pharmacology
        • Horses / metabolism
        • Injections, Intramuscular / veterinary
        • Keratan Sulfate / metabolism
        • Methylprednisolone / analogs & derivatives
        • Methylprednisolone / antagonists & inhibitors
        • Methylprednisolone / pharmacology
        • Methylprednisolone Acetate
        • Partial Thromboplastin Time / veterinary
        • Synovial Fluid / metabolism

        Grant Funding

        • AR-35664 / NIAMS NIH HHS

        Citations

        This article has been cited 2 times.
        1. White GW. Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data. Open Vet J 2025 Sep;15(9):4007-4023.
          doi: 10.5455/OVJ.2025.v15.i9.6pubmed: 41200294google scholar: lookup
        2. Palmer JL, Bertone AL, McClain H. Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease. Can J Vet Res 1995 Jul;59(3):205-12.
          pubmed: 8521354